119 related articles for article (PubMed ID: 9442316)
41. Mutagenic activation of aflatoxin B1 by pulmonary, renal, and hepatic cytochrome P450s from rats.
Imaoka S; Ikemoto S; Shimada T; Funae Y
Mutat Res; 1992 Oct; 269(2):231-6. PubMed ID: 1383706
[TBL] [Abstract][Full Text] [Related]
42. Hormonal regulation of rat renal cytochrome P450s by androgen and the pituitary.
Imaoka S; Yamazoe Y; Kato R; Funae Y
Arch Biochem Biophys; 1992 Nov; 299(1):179-84. PubMed ID: 1444448
[TBL] [Abstract][Full Text] [Related]
43. Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms.
Volk B; Meyer RP; von Lintig F; Ibach B; Knoth R
Toxicol Lett; 1995 Dec; 82-83():655-62. PubMed ID: 8597124
[TBL] [Abstract][Full Text] [Related]
44. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
Testai E; De Curtis V; Gemma S; Fabrizi L; Gervasi P; Vittozzi L
J Biochem Toxicol; 1996; 11(6):305-12. PubMed ID: 9176742
[TBL] [Abstract][Full Text] [Related]
45. Changes in the expression of cytochrome P450 isozymes and related carcinogen metabolizing enzyme activities in Schistosoma mansoni-infected mice.
Sheweita SA; Mubark J; Doenhofe MJ; Mostafa MH; Margison GP; O'Connor PJ; Elder RH
J Helminthol; 2002 Mar; 76(1):71-8. PubMed ID: 12018200
[TBL] [Abstract][Full Text] [Related]
46. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y
Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730
[TBL] [Abstract][Full Text] [Related]
47. Comparison in metabolic activity of cytochrome P450 1A1 on heterocyclic amines between human and rat.
Kanazawa K; Ashida H; Danno Gi
J Agric Food Chem; 1999 Dec; 47(12):4956-61. PubMed ID: 10606558
[TBL] [Abstract][Full Text] [Related]
48. Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms.
Rosenbrock H; Hagemeyer CE; Singeç I; Knoth R; Volk B
J Neuroendocrinol; 1999 Aug; 11(8):597-604. PubMed ID: 10447797
[TBL] [Abstract][Full Text] [Related]
49. Induction of cytochrome P450 isoforms by carcinogenic aromatic amines and carcinogenic susceptibility of rodent animals.
Hashimoto Y; Degawa M
Pharmacogenetics; 1995; 5 Spec No():S80-3. PubMed ID: 7581495
[TBL] [Abstract][Full Text] [Related]
50. Differential oxidase activity of hepatic and pulmonary microsomal cytochrome P-450 isozymes after treatment with cytochrome P-450 inducers.
Sakai H; Park SS; Kikkawa Y
Biochem Biophys Res Commun; 1992 Sep; 187(3):1262-9. PubMed ID: 1329733
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
[TBL] [Abstract][Full Text] [Related]
52. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.
Shimada T; Okuda Y
Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745
[TBL] [Abstract][Full Text] [Related]
53. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
Jalas JR; Ding X; Murphy SE
Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
[TBL] [Abstract][Full Text] [Related]
54. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes.
Yamazaki H; Inui Y; Wrighton SA; Guengerich FP; Shimada T
Carcinogenesis; 1995 Sep; 16(9):2167-70. PubMed ID: 7554070
[TBL] [Abstract][Full Text] [Related]
55. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.
Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R
Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981
[TBL] [Abstract][Full Text] [Related]
56. Effects of beta-ionone on the expression of cytochrome P450s and NADPH-cytochrome P450 reductase in Sprague Dawley rats.
Jeong TC; Gu HK; Chun YJ; Yun CH; Han SS; Roh JK
Chem Biol Interact; 1998 Jul; 114(1-2):97-107. PubMed ID: 9744558
[TBL] [Abstract][Full Text] [Related]
57. Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays.
Shimada T; Gillam EM; Sandhu P; Guo Z; Tukey RH; Guengerich FP
Carcinogenesis; 1994 Nov; 15(11):2523-9. PubMed ID: 7955101
[TBL] [Abstract][Full Text] [Related]
58. Benzylic hydroxylation of 1-methylpyrene and 1-ethylpyrene by human and rat cytochromes P450 individually expressed in V79 Chinese hamster cells.
Engst W; Landsiedel R; Hermersdörfer H; Doehmer J; Glatt H
Carcinogenesis; 1999 Sep; 20(9):1777-85. PubMed ID: 10469624
[TBL] [Abstract][Full Text] [Related]
59. Influence of recipient gender on cytochrome P450 isoforms expression in intrasplenic fetal liver tissue transplants in rats.
Lupp A; Hugenschmidt S; Danz M; Müller D
Toxicology; 2003 Jun; 188(2-3):171-86. PubMed ID: 12767689
[TBL] [Abstract][Full Text] [Related]
60. Evidence for O-dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain.
Parmar D; Dhawan A; Seth PK
Mol Cell Biochem; 1998 Dec; 189(1-2):201-5. PubMed ID: 9879672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
